Therapy-persistent leukemia is selectively vulnerable to SLC23A1 restoration via targeting KHSRP - Qingyu Luo; Karley S. Whalen; Xiaowei Wu; Amanda L. Fortune; Jacqueline S. Garcia; Kate Marinchev; Lin Zhang; Weiye Qian; Evangeline G. Raulston; Yabing Nan; Christopher A.G. Booth; Kezhi Yan; et al. (Blood Cancer Discovery, 2026)